<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03970499</url>
  </required_header>
  <id_info>
    <org_study_id>PHA017-IZ/ELASTOGLI</org_study_id>
    <nct_id>NCT03970499</nct_id>
  </id_info>
  <brief_title>Ultrasound Elastography and Ultrasentive Doppler for Surgery of Brain Tumors</brief_title>
  <acronym>ELASTOGLI</acronym>
  <official_title>Evaluation de l'intérêt de l'élastographie Ultrasonore et du Doppler Ultrasensible peropératoires Dans la Prise en Charge Chirurgicale Des Tumeurs cérébrales</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Tours</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Tours</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgery for brain gliomas is usually guided by different imaging techniques including
      neuronavigation MRI and intraoperative ultrasound that do not allow visualization of the
      low-density peri-lesional tumor infiltration present in gliomas and from which the tumor
      recurs.

      Another important aspect in the management of glial tumors is the histological grade. The
      appearance of new vessels (called neo-angiogenesis) is one of the crucial steps in the life
      of these tumors, which signifies the transition to anaplasia.

      This neoangiogenesis is diagnosed during the anatomopathological analysis of the operative
      specimen, and may be suspected on preoperative MRI on the so-called infusion sequences.

      The objective of this project is to evaluate the potential of two ultrasound modalities -
      elastography and ultrasensitive Doppler - in helping the surgical management of brain tumors.
      Ultrasound elastography measures cerebral elasticity and thus indirectly the degree of tumor
      infiltration; while ultrasensitive Doppler measures intratumoral vascularization, and could
      therefore help in the diagnosis of tumor anaplasia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Surgery for brain gliomas is usually guided by different imaging techniques including
      neuronavigation MRI and intraoperative ultrasound. Unfortunately, MRI and ultrasound do not
      allow visualization of the low-density peri-lesional tumor infiltration present in gliomas
      and from which the tumor recurs. Developing tools to identify this &quot;peritumoral&quot; infiltration
      zone is therefore a major issue in neuro-oncology.

      The consistency of brain tumors is a subjective criterion used in cerebral glioma surgery,
      the tumor area being firmer than the adjacent healthy brain. A pilot study was conducted from
      December 2012 to March 2014 by the Langevin Institute at La Pitié Salpêtrière. In this study,
      an intraoperative quantitative measurement of ultrasound elastography was performed on a
      cohort of patients with brain tumors. A significant difference between elasticity of low
      grade and high grade gliomas was found. However, in this study, no data on elasticity in a
      perilational infiltration zone is available.

      Another important aspect in the management of glial tumors is the histological grade. The
      appearance of new vessels (called neo-angiogenesis) is one of the crucial steps in the life
      of these tumors, which signifies the transition to anaplasia. This neoangiogenesis is
      diagnosed during the anatomopathological analysis of the operative specimen, and may be
      suspected on preoperative MRI on the so-called infusion sequences.

      The objective of this project is to evaluate the potential of two ultrasound modalities -
      elastography and ultrasensitive Doppler - in helping the surgical management of brain tumors,
      through intraoperative ultrasound. Ultrasound elastography measures cerebral elasticity and
      thus indirectly the degree of tumor infiltration; while ultrasensitive Doppler measures
      intratumoral vascularization, and can therefore help in the diagnosis of tumor anaplasia.

      Ultrasound elastography and ultrasensitive Doppler could enable us to more precisely target
      the more active tumoral territories (morphological criteria), to better identify the
      peri-lesional tumor infiltration in order to more precisely guide our resection procedure,
      and to provide additional information important for pathological analysis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2019</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ultrasound elastography measurements</measure>
    <time_frame>5 minutes, the day of surgery</time_frame>
    <description>Measure of cerebral ultrasound elasticity in three different areas: tumoral, peritumoral, and normal brain (in kPa)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ultrasound ultrasensitive doppler measurements</measure>
    <time_frame>5 minutes, the day of surgery</time_frame>
    <description>measurement perfusion by ultrasensitive doppler which consiste to map the power doppler amplitude ( % of vascularization)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparaison between ultrasound results and histology</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>histology criteria : type, gradation, neoangiogenesis molecular biology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between ultrasound results and MRI</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>MRI data : T1, hypersignal FLAIR, regional cerebral blood flow, diffusion</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Brain Tumor, Primary</condition>
  <arm_group>
    <arm_group_label>glial cerebral tumor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patient with an indication of glial cerebral tumor surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>brain tumor resection</intervention_name>
    <description>Intraoperative brain ultrasound elastography and ultrasensitive doppler during surgery</description>
    <arm_group_label>glial cerebral tumor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient with an indication for surgery of a glial cerebral tumor

          -  informed consent

          -  age &gt; 18

          -  social security regime

        Exclusion Criteria:

          -  patient with protection measures as &quot;tutelle or curatelle&quot;

          -  pregnant woman or woman without contraception measure

          -  patient under an exclusion period of another research
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ilyess ZEMMOURA, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU Tours FRANCE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ilyess ZEMMOURA, MD PhD</last_name>
    <phone>2 18 37 08 13</phone>
    <phone_ext>00 33</phone_ext>
    <email>ilyess.zemmoura@univ-tours.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Catherine ROUSSEL</last_name>
    <phone>2 47 47 97 89</phone>
    <phone_ext>00 33</phone_ext>
    <email>roussel@med.univ-tours.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ilyess ZEMMOURA</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilyess ZEMMOURA, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Lima GLO, Dezamis E, Corns R, Rigaux-Viode O, Moritz-Gasser S, Roux A, Duffau H, Pallud J. Surgical resection of incidental diffuse gliomas involving eloquent brain areas. Rationale, functional, epileptological and oncological outcomes. Neurochirurgie. 2017 Jun;63(3):250-258. doi: 10.1016/j.neuchi.2016.08.007. Epub 2017 Feb 1.</citation>
    <PMID>28161011</PMID>
  </results_reference>
  <results_reference>
    <citation>Mahboob S, McPhillips R, Qiu Z, Jiang Y, Meggs C, Schiavone G, Button T, Desmulliez M, Demore C, Cochran S, Eljamel S. Intraoperative Ultrasound-Guided Resection of Gliomas: A Meta-Analysis and Review of the Literature. World Neurosurg. 2016 Aug;92:255-263. doi: 10.1016/j.wneu.2016.05.007. Epub 2016 May 10. Review.</citation>
    <PMID>27178235</PMID>
  </results_reference>
  <results_reference>
    <citation>Ferraro N, Barbarite E, Albert TR, Berchmans E, Shah AH, Bregy A, Ivan ME, Brown T, Komotar RJ. The role of 5-aminolevulinic acid in brain tumor surgery: a systematic review. Neurosurg Rev. 2016 Oct;39(4):545-55. doi: 10.1007/s10143-015-0695-2. Epub 2016 Jan 27. Review.</citation>
    <PMID>26815631</PMID>
  </results_reference>
  <results_reference>
    <citation>Coburger J, Merkel A, Scherer M, Schwartz F, Gessler F, Roder C, Pala A, König R, Bullinger L, Nagel G, Jungk C, Bisdas S, Nabavi A, Ganslandt O, Seifert V, Tatagiba M, Senft C, Mehdorn M, Unterberg AW, Rössler K, Wirtz CR. Low-grade Glioma Surgery in Intraoperative Magnetic Resonance Imaging: Results of a Multicenter Retrospective Assessment of the German Study Group for Intraoperative Magnetic Resonance Imaging. Neurosurgery. 2016 Jun;78(6):775-86. doi: 10.1227/NEU.0000000000001081.</citation>
    <PMID>26516822</PMID>
  </results_reference>
  <results_reference>
    <citation>Gerard IJ, Kersten-Oertel M, Petrecca K, Sirhan D, Hall JA, Collins DL. Brain shift in neuronavigation of brain tumors: A review. Med Image Anal. 2017 Jan;35:403-420. doi: 10.1016/j.media.2016.08.007. Epub 2016 Aug 24. Review.</citation>
    <PMID>27585837</PMID>
  </results_reference>
  <results_reference>
    <citation>Chauvet D, Imbault M, Capelle L, Demene C, Mossad M, Karachi C, Boch AL, Gennisson JL, Tanter M. In Vivo Measurement of Brain Tumor Elasticity Using Intraoperative Shear Wave Elastography. Ultraschall Med. 2016 Dec;37(6):584-590. Epub 2015 Apr 15.</citation>
    <PMID>25876221</PMID>
  </results_reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 13, 2019</study_first_submitted>
  <study_first_submitted_qc>May 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2019</study_first_posted>
  <last_update_submitted>May 29, 2019</last_update_submitted>
  <last_update_submitted_qc>May 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>glioma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

